Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples

This publication has 20 references indexed in Scilit:

• Quantitative validation of an intracerebral β‐sensitive microprobe system to determine in vivo drug‐induced receptor occupancy using [¹¹C]raclopride in rats
  Synapse, 2004
• Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test
  Behavioural Pharmacology, 2003
• The Gerbil Elevated Plus-maze II Anxiolytic-like Effects of Selective Neurokinin NK1 Receptor Antagonists
  Neuropsychopharmacology, 2002
• Dopamine D2 Receptor Occupancy Is a Common Mechanism Underlying Animal Models of Antipsychotics and Their Clinical Effects
  Neuropsychopharmacology, 2001
• Dopamine D2 Receptor Blockade by Haloperidol 3H-Raclopride Reveals Much Higher Occupancy than EEDQ
  Neuropsychopharmacology, 2000
• Discrepancies in apparent dopamine D2 receptor occupancy between 3 H-raclopride and 3 H-N-methylspiperone
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
• Time Course of 5-HT2A Receptor Occupancy in the Human Brain after a Single Oral Dose of the Putative Antipsychotic Drug MDL 100,907 Measured by Positron Emission Tomography
  Neuropsychopharmacology, 1997
• Species differences in affinities of non-peptide antagonists for substance p receptors
  European Journal of Pharmacology, 1991
• Kinetic Evaluation for Measurement of in Vivo Receptor Occupancy by Psychotropic Drug in Brain: Implication for Human Studies.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1991